| Diagnosis | N | % | N | % | N | % | N | % | N | % |
|---|---|---|---|---|---|---|---|---|---|---|
| Endocervical adenocarcinoma | 13 | 0.2% | 10 | 0.6% | 8 | 0.5% | 0 | 0.0% | 31 | 0.3% |
| Squamous cell carcinoma | 33 | 0.6% | 29 | 1.8% | 7 | 0.5% | 0 | 0.0% | 69 | 0.8% |
| Other cervical carcinoma | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
| AIS | 18 | 0.3% | 23 | 1.4% | 4 | 0.3% | 0 | 0.0% | 45 | 0.5% |
| HSIL/CIN3 | 615 | 10.3% | 692 | 43.4% | 21 | 1.4% | 0 | 0.0% | 1,328 | 14.6% |
| HSIL/CIN2 | 327 | 5.5% | 235 | 14.8% | 3 | 0.2% | 1 | 5.6% | 566 | 6.2% |
| LSIL | 1,368 | 22.9% | 305 | 19.1% | 67 | 4.5% | 3 | 16.7% | 1,743 | 19.2% |
| Benign changes | 2,592 | 43.4% | 211 | 13.2% | 722 | 48.7% | 10 | 55.6% | 3,535 | 39.0% |
| No pathological findings | 777 | 13.0% | 79 | 5.0% | 651 | 43.9% | 2 | 11.1% | 1,509 | 16.6% |
| Evaluation not possible | 234 | 3.9% | 9 | 0.6% | 0 | 0.0% | 2 | 11.1% | 245 | 2.7% |
| Data not available | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
| Total | 5,977 | 100.0% | 1,593 | 100.0% | 1,483 | 100.0% | 18 | 100.0% | 9,071 | 100.0% |